Carregant...
Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung Cancer
Locally advanced non-small cell lung cancer (NSCLC) is a heterogeneous disease, and we have embarked on an era where patients will benefit from individualized therapeutic strategies based on identifiable molecular characteristics of the tumor. The landmark studies demonstrating the importance of mol...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Korean Cancer Association
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3394867/ https://ncbi.nlm.nih.gov/pubmed/22802745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2012.44.2.74 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|